From July 1, 2022 to September 30, 2022, the company has repurchased 1,500,000 shares, representing 1.65% for $364.64 million. With this, the company has completed the repurchase of 6,735,604 shares, representing 7.2% for $1,769.37 million under the buyback announced on December 9, 2021.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
204.2 USD | +2.91% | +0.54% | -10.17% |
04-29 | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
04-29 | US FDA publishes final rule for laboratory developed tests | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.17% | 17.21B | |
-14.58% | 85.02B | |
+15.05% | 82.37B | |
+10.49% | 29.29B | |
-1.39% | 16.7B | |
-31.58% | 11.8B | |
+1.82% | 12.15B | |
+31.86% | 12.12B | |
-0.47% | 12.13B | |
-8.00% | 11.67B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on December 9, 2021.